Lunch Session Sponsored by Bayer

12:30-14:00   Wednesday, 25 April, 2017
Lunch session Sponsored by Bayer - Hall H - Haifa
INTEGRATED CARDIOVASCULAR RISK MANAGEMENT: ANTICOAGULATION IN THE MULTI- MORBID PATIENTS – CHALLENGES AND OPPORTUNITIES
CHAIR: PROF. DORON ZAHGER , CARDIOLOGY DIVISION, SOROKA MEDICAL CENTER

 

 
 Time TopicSpeaker
 12:50-13:05Efficacy and Safety of Noval Oral Anticoagulants in Patients with Renal Dysfunction and Atrial Fibrillation: Real World Data from a Prospective Multicenter RegistryProf. Ilan Goldenberg, Cardiology Department, Sheba Medical Center
 13:05-13:20Managing Atrial Fibrillation in patients with Diabetes MellitusProf. Shaul Atar, Cardiology Division, Galilee Medical Center
 13:20-13:35The NOAC use in ACSProf. Shlomi Matetzky, Heart Center, Sheba Medical Center
 13:35- 13:50Panel Discussion

Chairman: Prof. Doron Zahger Panel Members: Prof. Shlomi Matetzky, Prof. Shaul Atar ,Prof. Ilan Goldenberg

 13:50- 14:00 Q & A 


To Register Click Here